Unknown NA INTERVENTIONAL 1-arm NCT04704414

Exophthalmometry With 3D Face Scanners (EX3D)

Sponsor: University of Zurich

Conditions Exophthalmos Graves Ophthalmopathy Orbital Fractures Orbital Tumor

Updated 4 times since 2021 Last updated: Jan 10, 2021 Started: Aug 14, 2019 Primary completion: Dec 31, 2021 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Exophthalmos and Graves Ophthalmopathy and is currently ongoing. University of Zurich leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Recruiting NA

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Zurich

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland